查看全部

肿瘤

急性髓系白血病

肾上腺皮质癌

膀胱尿路上皮癌

ALTTO试验终期分析：HER2阳性早期乳腺癌患者辅助性曲妥珠单抗与拉帕替尼的序贯或联合方案【BIG 2-06/NCCTG N063D（联盟）】

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

DOI 原文链接

用sci-hub下载

ESMO Open

正在获取期刊数据...

发表日期:2024 Nov

作者:

DOI:10.1016/j.esmoop.2024.103938

摘要

AI正在翻译并加载中文摘要...

ALTTO试验终期分析：HER2阳性早期乳腺癌患者辅助性曲妥珠单抗与拉帕替尼的序贯或联合方案【BIG 2-06/NCCTG N063D（联盟）】

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

摘要

Abstract